Cipremi Cipla News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bring Remdesivir under drug price control: Maha Barrister ​ Fri, Apr 16 2021 8:21 IST | ​ 5 Views   Mumbai, April 16 : A prominent Maharashtra legal luminary has petitioned the Centre to declare the Remdesivir medicine - currently in huge demand owing to the Covid-19 pandemic - as a 'life-saving' medicine with controlled pricing to prevent blackmarketing and corruption. Remdesivir is manufactured by a handful of companies under brand names like Cipremi (Cipla), Covifar (Hetero), Desrem (Mylon), Remdac (Zydus), Redyx (Dr. Reddy's). In a plea to the Central Government which controls the...

COVID-19: Want to check availability of Remdesivir, hospital beds in India? Visit THESE websites The anti-viral drug Remdesivir is considered a key drug in the fight against COVID-19, especially in adult patients with severe complications. Share Updated: Apr 16, 2021, 09:45 PM IST Amid the sudden surge in COVID-19 cases across the country, several states have witnessed shortage of the anti-viral drug Remdesivir. The anti-viral drug Remdesivir is considered a key drug in the fight against COVID-19, especially in adult patients with severe complications. Remdesivir helps shorten recovery time f...